1,504
Views
57
CrossRef citations to date
0
Altmetric
Articles

Antihypertensive peptides of animal origin: A review

, &

References

  • Abubakar, A., Saito, T., Kitazawa, H., Kawai, Y. and Itoh, T. (1998). Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion. J. Dairy Sci. 81:3131–3138.
  • Adje, E. Y., Balti, R., Kouach, M., Guillochon, D. and Nedjar-Arroume, N. (2011). α 67–106 of bovine hemoglobin: A new family of antimicrobial and angiotensin I-converting enzyme inhibitory peptides. Eur. Food Res.Technol. 232:637–646.
  • Aihara, K., Kajimoto, O., Hirata, H., Takahashi, R. and Nakamura, Y. (2005). Effect of powdered fermented milk with Lactobacillus helveticus on subjects with highnormal blood pressure or mild hypertension. J. Am. Coll. Nutr. 24:257–265.
  • Allender, P. S., Cutler, J. A., Follmann, D., Cappuccio, F. P., Pryer, J. and Elliott, P. (1996). Dietary calcium and blood pressure: A meta-analysis of randomized controlled trials. Ann. Intern. Med. 124:825–831.
  • American Heart Association. (2013). High Blood Pressure-Statistical fact sheet 2013 update. Available from https://www.heart.org/idc/groups/heartpublic/@wcm/@sop/@smd/documents/downloadable/ucm_319587.pdf.
  • Appel, L. J., Frohlich, E. D., Hall, J. E., Pearson, T. A., Sacco, R. L., Seals, D. R., Sacks, F. M., Smith, S. C, Jr. Vafiadis, D. K., Van Horn, L. V. (2011). The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: A call to action from the American Heart Association. Circulation 123:1138–1143.
  • Ardo, Y., Lilbaek, H., Kristiansen, K. R., Zakora, M. and Otte, J. (2007). Identification of large phosphopeptides from β-casein that characteristically accumulate during ripening of the semihard cheese Herrga° rd. Int. Dairy J. 17:513–524.
  • Arihara, K., Nakashima, Y., Mukai, T., Ishikawa, S. and Itoh, M. (2001). Peptide inhibitors for angiotensin I-converting enzyme from enzymatic hydrolysates of porcine skeletal muscle proteins. Meat Sci. 57:319–324.
  • Ashar, M. N. and Chang, R. (2004). Fermented milk containing ACE-inhibitory peptides reduces blood pressure in middle aged hypertensive subjects. Milchwissenschaft 59:363–366.
  • Belem, M. A. F., Gibbs, B. F. and Lee, B. H. (1999). Proposing sequences for peptides derived from whey fermentation with potential bioactive sites. J. Dairy Sci. 82:486–493.
  • Benamer, H. T. and Grosset, D. (2009). Stroke in Arab countries: A systematic literature review. J. Neurol. Sci. 284:18–23.
  • Boelsma, E. and Kloek, J. (2009). Lactotripeptides and antihypertensive effects: A critical review. Br. J. Nutr. 101:776–786.
  • Boelsma, E. and Kloek, J. (2010). IPP-rich milk protein hydrolysate lowers blood pressure in subjects with stage 1 hypertension, a randomized controlled trial. Nutri. J. 9:52.
  • Bu¨tikofer, U., Meyer, J., Sieber, R. and Wechsler, D. (2007). Quantification of the angiotensin-converting enzymeinhibiting tripeptides Val-Pro-Pro and Ile-Pro-Pro in hard, semi-hard and soft cheeses. Int. Dairy J. 17:968–975.
  • Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T. and Roccella, E. J. (2003). The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289:2560–2571.
  • Chobert, J. M., El-Zahar, K., Sitohy, M., Dalgalarrondo, M., Me´tro, F., Choiset, Y. and Haertle, T. (2005). Angiotensin I-convertingenzyme (ACE) inhibitory activity of tryptic peptides of ovine blactoglobulin and of milk yoghurts obtained by using different starters. Lait. 85:141–152.
  • Danaei, G., Ding, E. L., Mozaffarian, D., Taylor, B., Rehm, J., Murray, C. J. L. and Ezzati, M. (2009). The preventable causes of death in the United States: Comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 6(4):e1000058.
  • Davalos, A., Miguel, M., Bartolome, B. and Lopez-Fandino, R. (2004). Antioxidant activity of peptides derived from egg white proteins by enzymatic hydrolysis. J. Food Prot. 67:1939–1944.
  • de Leeuw, P. W., van der Zander, K., Kroon, A. A., Rennenberg, R. M. and Koning, M. M. (2009). Dose-dependent lowering of blood pressure by dairy peptides in mildly hypertensive subjects. Blood Press. 18:44–50.
  • Egan, B. M., Zhao, Y., Axon, R. N. (2010). US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 303:2043–2050.
  • Elliott, P., Kesteloot, H., Appel, L. J., Dyer, A. R., Ueshima, H., Chan, Q., Brown, I. J., Zhao, L. and Stamler, J. (2008). INTERMAP Cooperative Research Group: Dietary phosphorus and blood pressure: International study of macro- and micro-nutrients and blood pressure. Hypertension 51:669–675.
  • Engberink, M. F., Schouten, E. G., Kok, F. J., van Mierlo, L. A., Brouwer, I. A., Geleijnse, J. M. (2008). Lactotripeptides show no effect on human blood pressure: Results from a double-blind randomized controlled trial. Hypertension 51:399–405.
  • Ferranti, P., Barone, F., Chianese, L., Addeo, F., Scaloni, A., Pellegrino, L. and Resmini, P. (1997). Phosphopeptides from Grana Padano cheese: Nature, origin and changes during ripening. J. Dairy Res. 64:601–615.
  • FitzGerald, R. J. and Meisel, H. (2000). Milk protein derived peptide inhibitors of angiotensin-I converting enzyme. Brit. J. Nurtr. 84:S33–S37.
  • FitzGerald, R. and Murray, B. A. (2006). Bioactive peptides and lactic fermentations. Int. J. Dairy Technol. 59:118–125.
  • FitzGerald, R. J., Murray, B. A. and Walsh, D. J. (2004). Hypotensive peptides from milk proteins. J. Nutr. 134:980S–88S.
  • Fujita, H., Sasaki, R. and Yoshikawa, M. (1995). Potentiation of the antihypertensive activity of orally administered Ovokinin, a vasorelaxing peptide derived from ovalbumin, by emulsifi cation in egg phosphatidyl-choline. Biosci. Biotechnol. Biochem. 59:2344–2345.
  • Fujita, H., Usui, H., Kurahashi, K. and Yoshikawa, M. (1995a). Isolation and characterization of ovokinin, a bradykinin B1 agonist peptide derived from ovalbumin. Peptides 46:785–790.
  • Fujita, H., Yamagami, T. and Ohshima, K. (2001). Effects of an ACE-inhibitory agent, katsuobushi oligopeptide, in the spontaneously hypertensive rat and in borderline and mildly hypertensive subjects. Nutr. Res. 21:1149–1158.
  • Fujita, H., Yokoyama, K. and Yoshikawa, M. (2000). Classification and antihypertensive activity of angiotensin I-converting enzyme inhibitory peptides derived from food proteins. J. Food Sci. 65:564–569.
  • Fu-yuan, C., Yu-tse, L., Tien-chun, W., Liang-chuan, L. and Sakata, R. (2008). The development of angiotensin I-converting enzyme inhibitor derived from chicken bone protein. Animal Science Journal 79:122–128.
  • Gagnaire, V., Molle, D., Herrouin, M. and Leonil, J. (2001). Peptides identified during Emmental cheese ripening: Origin and proteolytic systems involved. J. Agric. Food Chem. 49:4402–4413.
  • Garcia-Palmieri, M. R., Costas, R., Jr Cruz-Vidal, M., Sorlie, P. D., Tillotson, J. and Havlik, R. J. (1984). Milk consumption, calcium intake, and decreased hypertension in Puerto Rico. Puerto Rico Heart Health Program Study. Hypertension 6:322–328.
  • Gatnau, R., Polo, J. and Robert, E. (2001). Plasma protein antimicrobial substitution at negligible risk. Cahiers Options Mediterraneennes 54:141–150.
  • Gobbetti, M., Minervini, F. and Rizzello, C. G. (2004). Angiotensin I-converting-enzyme-inhibitory and antimicrobial bioactive peptides. Int. J. Dairy Technol. 57:172–188.
  • Gobbetti, M., Minervini, F. and Rizzello, C. G. (2007). In: Handbook of food products manufacturing, pp. 489–517. Hui, Y. H., Ed., John Wiley and Sons Inc, Hoboken, New Jersey.
  • Gobbetti, M., Stepaniak, L., De Angelis, M., Corsetti, A. and Di Cagno, R. (2002). Latent bioactive peptides in milk proteins: Proteolytic activation and significance in dairy processing. Crit Rev. Food Sci. Nutr. 42:223–239.
  • Gomez-Ruiz, J. A., Ramos, M. and Recio, I. (2002). Angiotensin-converting-enzyme-inhibitory peptides in Manchengo cheeses manufactured with different starter cultures. Int. Dairy J. 12:697–706.
  • Gomez-Ruiz, J. A., Ramos, M. and Recio, I. (2004). Angiotensin converting enzyme-inhibitory activity of peptides isolated from Manchego cheese. Stability under simulated gastrointestinal digestion. Int. Dairy J. 14:1075–1080.
  • Griffith, L. E., Guyatt, G. H., Cook, R. J., Bucher, H. C., Cook, D. J. (1999). The influence of dietary and nondietary calcium supplementation on blood pressure: An updated meta-analysis of randomized controlled trials. Am. J. Hypertens. 12:84–92.
  • Hajjar, I., Kotchen, J. M., Kotchen, T. A. (2006). Hypertension: Trends in prevalence, incidence, and control. Annu. Rev. Public Health 27:465–490.
  • Hajjarm, I., Kotchen, T. A. (2003). Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 290:199–206.
  • Hartmann, R. and Meisel, H. (2007). Food-derived peptides with biological activity: From research to food applications. Curr. Opinion Biotechnol. 18:163–169.
  • Hata, Y., Yamamoto, M., Ohni, H., Nakajima, K., Nakamura, Y. and Takano, T. (1996). A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am. J. Clin. Nutr. 64:767–771.
  • Herna´ndez-Ledesma, B., Amigo, L., Ramos, M. and Recio, I. (2004a). Angiotensin converting enzyme inhibitory activity in commercial fermented products. Formation of peptides under simulated gastrointestinal digestion. J. Agric. Food Chem. 52:1504–1510.
  • Herna´ndez-Ledesma, B., Amigo, L., Ramos, M. and Recio, I. (2004b). Release of angiotensin converting enzyme-inhibitory peptides by simulated gastrointestinal digestion of infant formulas. Int. Dairy J. 14:889–898.
  • Higurashi, S., Kunieda, Y., Matsuyama, H. and Kawakami, H. (2007). Effect of cheese consumption on the accumulation of abdominal adipose and decrease in serum adiponectin levels in rats fed a calorie dense diet. Int. Dairy J. 17:1224–1231.
  • Himmelmann, A., Hedner, T., Hansson, L., O'Donnell, C. J. and Levy, D. (1998). Isolated systolic hypertension: An important cardiovascular risk factor. Blood Press. 7:197–207.
  • Hirota, T., Ohki, K., Kawagishi, R., Kajimoto, Y., Mizuno, S., Nakamura, Y. and Kitakaze, M. (2007). Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: Contribution of the inhibitory action of angiotensin-converting enzyme. Hypertens Res. 30:489–496.
  • Hong, F., Ming, L., Yi, S., Zhanxia, L., Yongquan, W. and Chi, L. (2008). The antihypertensive effect of peptides: A novel alternative to drugs? Peptides 29:1062–1071.
  • Houston, M. C. (2007). Treatment of hypertension with nutraceuticals, vitamins, antioxidants and minerals. Expert Rev. Cardiovasc. Ther. 5:681–691.
  • Hsieh, Y. H. and Ofori, J. (2011). In: Handbook of Analysis of Edible Animal by-Products, pp. 13–35, Nollet, L.M.L., Toldrá, F., Eds. CRC Press, Boca Raton, Florida, USA.
  • Hyun, C. K. and Shin, H. K. (1998). Utilization of bovine blood plasma obtained from a slaughterhouse for economic production of probiotics. J. Ferment. Bioeng. 86:34–37.
  • Jakala, P. and Vapaatalo, H. (2010). Antihypertensive peptides from milk proteins. Pharmaceuticals 3:251–272.
  • Jang, A. and Lee, M. (2005). Purification and identification of angiotensin converting enzyme inhibitory peptides from beef hydrolysates. Meat Sci. 69:653–661.
  • Jarmolowska, B., Kostyra, E., Krawczuk, S. and Kostyra, H. (1999). Beta-casomorphin-7 isolated from Brie cheese. J. Sci. Food Agric. 79:1788–1792.
  • Jauhiainen, T., Vapaatalo, H., Poussa, T., Kyronpalo, S., Rasmussen, M., Korpela, R. (2005). Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. Am. J. Hypertens. 18:1600–1605.
  • Jee, S. H., Miller, E. R. III., Guallar, E., Singh, V. K., Appel, L. J., Klag, M. J. (2002). The effect of magnesium supplementation on blood pressure: A meta-analysis of randomized clinical trials. Am. J. Hypertens. 15:691–696.
  • Kannel, W. B. (1993). Hypertension as a risk factor for cardiac events—epidemiologic results of long-term studies. J Cardiovasc Pharmacol. 21:S27–S37.
  • Kannel, W. B. (1995). Framingham study insights into hypertensive risk of cardiovascular disease. Hypertens Res.18:181–196.
  • Katayama, K., Anggraeni, H. E., Mori, T., Ahhmed, A. A., Kawahara, S., Sugiyama, M., Nakayama, T., Maruyama, M. and Mugurumat, M. (2008). Porcine skeletal muscle troponin is a good source of peptides with angiotensin-I converting enzyme inhibitory activity and anti hypertensive effects in spontaneously hypertensive rats. J. Agric. Food Chem. 56:355–360.
  • Katayama, K., Mori, T., Kawahara, S., Miake, K., Kodama, Y., Sugiyama, M., Kawamura, Y., Nakayama, T., Maruyama, M., Muguruma, M. (2007). Angiotensin-I converting enzyme inhibitory peptide derived from porcine skeletal muscle myosin and its antihypertensive activity in spontaneously hypertensive rats. J. Food Sci. 72:S702–S706.
  • Katayama, K., Tomatsu, M., Fuchu, H., Sugiyama, M., Kawahara, S., Yamauchi, K., Kawamura, Y. and Muguruma, M. (2003). Purification and characterization of an angiotensin I converting enzyme inhibitory peptide derived from porcine troponin C. Anim. Sci. J. 74:53–58.
  • Kawasaki, T., Seki, E., Osajima, K., Yoshida, M., Asada, K., Matsui, T. and Osajima, Y. (2000). Antihypertensive effect of valyl-tyrosine, a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects. J. Human Hypertens. 14:519–523.
  • Kazunori, K., Tomatsu, M., Fuchu, H., Sugiyama, M., Kawahara, S., Yamauchi, K. and Kawamura Y. (2003). Purification and characterization of an angiotensin I-converting enzyme inhibitory peptide derived from porcine troponin C. Anim. Sci. J. 74:53–58.
  • Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K. and He, J. (2005). Global burden of hypertension: Analysis of worldwide data. Lancet. 365:217–223.
  • Kim, S. K., Byun, H. G., Park, P. J. and Shahidi, F. (2001). Angiotensin I converting enzyme inhibitory peptides purified from bovine skin gelatin hydrolysate. J. Agric. Food Chem. 49:2992–2997.
  • Kitts, D. D., and Weiler, K. (2003). Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Current Pharmaceutical Design 9:1309–1323.
  • Korhonen, H. (2002). Technology options for new nutritional concepts. Int J Dairy Technol 55:79–88.
  • Korhonen, H. (2009). Milk-derived bioactive peptides: From science to applications. J. Funct Foods 1:177–187.
  • Korhonen, H. and Pihlanto, A. (2003a). Food-derived bioactive peptides-opportunities for designing future foods. Curr. Pharm. Design 9:1297–1308.
  • Korhonen, H. and Pihlanto, A. (2003b). Bioactive peptides: Novel applications for milk proteins. Appl. Biotechnol. Food Sci. Pol. 1:133–144.
  • Korhonen, H. and Pihlanto, A. (2006). Bioactive peptides: Production and functionality. Int. Dairy J. 16:945–960.
  • Korhonen, H. and Pihlanto, A. (2007). Technological options for the production of health-promoting proteins and peptides derived from milk and colostrum. Curr. Pharm. Design 13:829–843
  • Korhonen, H. and Pihlanto-Leppa¨ la¨, A. (2004). In: Handbook of functional dairy products. pp. 109–124, Shortt, C. and O'Brien, J., Eds., Functional Foods and Nutraceuticals Series 6.0, CRC Press, Florida, USA.
  • Kris-Etherton, P.M., Grieger, J.A., Hilpert, K.F. and West, S.G. (2009). Milk products, dietary patterns and blood pressure management. J. Am. Coll. Nutr. 28:103S–119S.
  • Krousel-Wood, M., Thomas, S., Muntner, P., and Morisky, D. (2004). Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Current Opinion in Cardiology 19(4):357–362.
  • The Lancet Editorial. (1980). Captopril: Benefits and Risks in Severe Hypertension. The Lancet 316:129–130.
  • Lantz, I., Glamsta, E. L., Talback, L. and Nyberg, F. (1991). Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting enzyme activity. FEBS Lett 287:39–41.
  • Lawes, C. M., Vander Hoorn, S. and Rodgers, A. (2008). International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet. 371:1513–1518.
  • Lee, Y. M., Skurk, T., Hennig, M. and Hauner, H. (2007). Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension. Eur. J. Nutr. 46:21–27.
  • Lewington, S., Clarke, R., Qizilbash, N., Peto, R. and Collins, R. (2002). Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 360:1903–1913.
  • Liu, J. B., Yu, Z. P., Zhao, W. Z., Lin, S. Y., Wang, E. L., Zhang, Y., Hao, Y., Wang, Z. Z. and Chen, F. (2010). Isolation and identification of angiotensin-converting enzyme inhibitory peptides from egg-white protein hydrolysates. Food Chem. 122:1159–1163.
  • López-Fandiño, R., Otte, J. and van Camp, J. (2006). Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity. Int. Dairy J. 16:1277–1293.
  • Lo´pez-Fandi˜No, R., Recio, I. and Ramos, M. (2007). Egg-protein-derived peptides with antihypertensive activity. In: Bioactive Egg Compounds, pp. 199–222, Huopalahti, R., López-Fandin˜o, R., Anton, M. and Schade, R., Eds., Springer-Verlag Berlin, Heidelberg.
  • Maeno, M., Yamamoto, N. and Takano, T. (1996). Identification of antihypertensive peptides from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 73:1316–1321.
  • Maruyama, S. and Suzuki, H. (1982). A peptide inhibitor of angiotensin I-converting enzyme in the tryptic hydrolysate of casein. Agric. Biol. Chem. 46:1393–1394.
  • Masuda, O., Nakamura, Y. and Takano, T. (1996). Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J. Nutr. 126:3063–3068.
  • Matoba, N., Usui, H., Fujita, H. and Yoshikawa, M. (1999). A novel anti-hypertensive peptide derived from ovalbumin induces nitric oxide-mediated vasorelaxation in an isolated SHR mesenteric artery. FEBS Lett. 452:181–184.
  • Matoba, N., Yamada, Y., Usui, H., Nakagiri, R. and Yoshikawa, M. (2001). Designing potent derivatives of ovokinin (2–7), an anti-hypertensive peptide derived from ovalbumin. Biosci. Biotechnol. Biochem. 65:736–739.
  • McCann, K. B., Shiellb, B. J., Michalskib, W. P., Leec, A., Wanc, J., Roginskia, H., et al., 2005. Isolation and characterization of antibacterial peptides derived from the f (164–207) region of bovine aS2-casein. Int. Dairy J. 15:133–143.
  • McCarron, D. A., Morris, C. D., Henry, H. J. and Stanton, J. L. (1984). Blood pressure and nutrient intake in the United States. Science (New York) 224:1392–1398.
  • Meisel, H. (1998). Overview on milk protein-derived peptides. Int. Dairy J. 8:363–373.
  • Meisel, H. (2001). Bioactive peptides from milk proteins: A perspective for consumers and producers. Aus. J. Dairy Technol. 56:83–91.
  • Meisel, H., Goepfert, A. and Gunther, S. (1997). ACE-inhibitory activities in milk products. Milchwissenschaft 52:307–311.
  • Meisel, H. and Schlimme, E. (1994). Inhibitors of angiotensin-converting enzyme derived from bovine casein (casokinins). In: β-Casomorphins and Related Peptides: Recent Developments. pp. 27–33, Brantl, V. and Teschemacher, H., Eds., Weinheim, VCH.
  • Meisel, H. and Schlimme, E. (1996). Bioacive peptides derived from milk proteins: Ingredients for functional foods. Kieler Milchwirtschaftliche Forschungsberichte 48:343–357.
  • Migliore-Samour, D. and Jollés, P. (1988). Casein, a prohormone with an immunomodulating role for the newborn? Experientia. 44:188–193.
  • Miguel, M., Aleixandre, M. A., Ramos, M. and López-Fandiño, L. (2006) Effect of simulated gastrointestinal digestion on the antihypertensive properties of ACE-inhibitory peptides derived from ovalbumin. J. Agric. Food Chem. 54:726–731.
  • Miguel, M., Alvarez, Y., Lopez-Fandino, R., Alonso, M. and Salaices, M. (2007). Vasodilator effects of peptides derived from egg white proteins. Regulatory Peptides 140:131–135.
  • Miguel, M., Lopez-Fandino, R., Ramos, M. and Aleixandre, A. (2005). Short-term effect of egg white hydrolysate products on the arterial blood pressure of hypertensive rats. Brit. J. Nutr. 94:731–737.
  • Miguel, M., Recio, I., Gomez-Ruiz, J. A., Ramos, M. and Lopez-Fandino, R. (2004). Angiotensin-I-converting enzyme inhibitory activity of peptides derived from egg white proteins by enzymatic hydrolysis. J. Food Prot. 67:1914–1920.
  • Mine, Y. and Kovacs-Nolan, J. (2005). New insights in biologically active proteins and peptides derived from hen egg. Paper presented in: XIth European Symposium, Quality of Eggs and Egg Products, Doorwerth, The Netherlands, 23–26 May 2005.
  • Mizuno, S., Nishimura, S., Matsuura, K., Gotou, T. and Yamamoto, N. (2004). Release of short and proline rich antihypertensive peptides from casein hydrolyzate with an Aspergillus oryzae protease. J. Dairy Sci. 87:3183–3188.
  • Mizushima, S., Ohshige, K., Watanabe, J., Kimura, M., Kadowaki, T., Nakamura, Y., Tochikubo, O. and Ueshima, H. (2004). Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. Am. J. Hypertens. 17:701–706.
  • Mizuno, S., Matsuura, K., Gotou, T., Nishimura, S., Kajimoto, O., Yabune, M., Kajimoto, Y., and Yamamoto, N. (2005). Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. British Journal of Nutrition 94:84–91.
  • Muehlenkamp, M. R. and Warthesen, J. J. (1996). Beta-casomorphins: Analysis in cheese and susceptibility to proteolytic enzymes from Lactococcus lactis ssp. Cremoris. J. Dairy Sci. 79:20–26.
  • Mullally, M. M., Meisel, H. and FitzGerald, R. J. (1997). Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine b-lactoglobulin. FEBS Lett. 402:99–101.
  • Murakami, M., Tonouchi, H., Takahashi, R., Kitazawa, H., Kawai, Y., Negishi, H. and Saito, T. (2004). Structural analysis of a new anti-hypertensive peptide (β-lactosin B) isolated from a commercial whey product. J. Dairy Sci. 87:1967–1974.
  • Nakamura, Y., Yamamoto, N., Sakai, K., Okubo, A., Yamazaki, S. and Takano, T. (1995a). Purification and chracterization of angiotensin I-converting enzyme inhibitors from sour milk. J. Dairy Sci. 78:777–783.
  • Nakamura, Y., Yamamoto, N., Sakai, K. and Takano, T. (1995b). Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to Angiotensin I-converting enzyme. J. Dairy Sci. 78:1253–1257.
  • Nakashima, Y., Arihara, K., Sasaki, A., Ishikawa, S. and Itoh, M. (2002). Antihypertensive activities of peptides derived from porcine skeletal muscle myosin in spontaneously hypertensive rats. J. Food Sci. 67:434–437.
  • Nedjar-Arroume, N., Dubois-Delval, V., Adje, E. Y., Traisnel, J., Krier, F., Mary, P., Kouach, M., Briand, G. and Guillochon, D. (2008). Bovine hemoglobin: An attractive source of antibacterial peptides. Peptides 29:969–977.
  • Neutel, J. M., Nonaka, M., Hendler, S., Weber, M. A. (2006). The use of amealpeptide in the treatment of patients with stage I and stage II hypertension-data from the AHEAD study. J Hypertens 24(suppl 4):S84.
  • Nurminen, M. L., Sipola, M., Kaarto, H., et al. (2000). Alpha-lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sci 66:1535–1543.
  • Ong, L., Henriksson, A. and Shah, N. P. (2007). Angiotensin converting enzyme-inhibitory activity in Cheddar cheeses made with the addition of probiotic Lactobacillus casei sp. Lait 87:149–165.
  • Pares, D., Saguer, E. and Carretero, C. (2011). In: Processed Meats: Improving Safety, Nutrition and Quality. pp. 218–242, Kerry, J. P., Kerry, J. F., Eds., Wood head Publishing Ltd., Cambridge.
  • Parrot, S., Degraeve, P., Curia, C. and Martial-Gros, A. (2003). In vitro study on digestion of peptides in Emmental cheese: Analytical evaluation and influence on angiotensin I converting enzyme inhibitory peptides. Nahrung 47:87–94.
  • Perpetuo, E., Juliano, L. and Lebrun, I. (2003). Biochemical and pharmacological aspects of two bradykinin-potentiating peptides obtained from tryptic hydrolysis of casein. J. Protein Chem. 22:601–606.
  • Pihlanto-Leppa¨ la¨, A., Koskinen, P., Piilola, K., Tupasela, T. and Korhonen, H. (2000). Angiotensin I-converting enzyme inhibitory properties of whey protein digests: Concentration and characterization of active peptides. J. Dairy Res. 67:53–64.
  • Pihlanto-Leppä lä, A., Rokka, T. and Korhonen, H. (1998). Angiotensin I-converting enzyme inhibitory peptides derived from bovine milk proteins. Int. Dairy J. 8:325–331.
  • Pins, J. J. and Keenan, J. M. (2006). Effects of whey peptides on cardiovascular disease risk factors. J. Clin. Hypertens. 8:775–782.
  • Pouliot, Y., Gauthier, S. F., and Groleau, P. E. (2006). Membrane-based fractionation and purification strategies for bioactive peptides. In: Y Mine, F Shahidi, eds., Nutraceutical proteins and peptides in health and disease, 639–658. Boca Raton, FL: CRC Press.
  • Quiros, A., Hernandez-Ledesma, B., Ramos, M., Amigo, L. and Recio, I. (2005). Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir. J. Dairy Sci. 88:3480–3487.
  • Reed, D., McGee, D., Yano, K. and Hankin, J. (1985). Diet, blood pressure, and multicollinearity. Hypertens. 7:405–410.
  • Rihanen, E. L., Pihlanto-Leppala, A. and Pahkala, E. (2001). A new type of ripened, low-fat cheese with bioactive properties. Int. Dairy J. 11:SI–441.
  • Rokka, T., Syvoja, E. L., Tuominen, J. and Korhonen, H. (1997). Release of bioactive peptides by enzymatic proteolysis of Lactobacillus GG fermented UHT milk. Milchwissenschaft 52:675–678.
  • Roudot-Algaron, F., LeBars, D., Kerhoas, L., Einhorn, J. and Gripon, J. C. (1994). Phosphopeptides from Comté cheese: Nature and origin. J. Food Sci. 59:544–550.
  • Rudkowska, I., Jones, P. J. (2007). Functional foods for the prevention and treatment of cardiovascular diseases: Cholesterol and beyond. Expert Rev. Cardiovasc. Ther. 5:477–490.
  • Ryan, J. T., Ross, R. P., Bolton, D., Fitzgerald, G. F. and Stanton, C. (2011). Bioactive peptides from muscle sources: Meat and fish. Nutrients 3:765–791.
  • Ryhänen, E. L., Pihlanto-Leppälä, A. and Pahkala, E. (2001). A new type of ripened, low-fat cheese with bioactive properties. Int. Dairy J. 11:441–447.
  • Sabikhi, L. and Mathur, B. N. (2001). Qualitative and quantitative analysis of b-casomorphins in Edam cheese. Milchwissenschaft 56:198–200.
  • Saiga, A., Okumura, T., Makihara, T., Katsuta, S., Shimizu, T., Yamada, R., et al. (2003). Angiotensin I-converting enzymes inhibitory peptides in a hydrolyzed chicken breast muscle extract. J. Agric. Food Chem. 51:1740–1745.
  • Saito, T., Nakamura, T., Kitazawa, H., Kawai, Y. and Itoh, T. (2000). Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese. J. Dairy Sci. 83:1434–1440.
  • Sakanaka, S. and Tachibana, Y. (2006). Active oxygen scavenging activity of egg-yolk protein hydrolysates and their effects on lipid oxidation in beef and tuna homogenates. Food Chem. 95:243–249.
  • Samaranayaka, A. G. P., Kitts, D. D. and Li-Chan, E. C. Y. (2010). Antioxidative and angiotensin-I-converting enzyme inhibitory potential of a Pacific hake (Merluccius productus) fish protein hydrolysate subjected to simulated gastrointestinal digestion and Caco-2 cell permeation. J. Agric. Food Chem. 58:1535–1542.
  • Sano, J., Ohki, K., Higuchi, T., Aihara, K., Mizuno, S., Kajimoto, O., Nakagawa, S., Kajimoto, Y. and Nakamura, Y. (2005). Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension. J. Med. Food 8:423–430.
  • Sekiya, S., Kobayashi, Y., Kita, E., Imamura, Y. and Toyama, S. (1992). Antihypertensive effects of tryptic hydrolysate of casein on normotensive and hypertensive volunteers. J. Jap. Soc. Nutr. Food Sci. 45:513–517.
  • Seppo, L., Jauhiainen, T., Poussa, T. and Korpela, R. (2003). A fermented milk high inbioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am. J. Clin. Nutr. 77:326–330.
  • Seppo, L., Kerojoki, O., Suomalainen, T. and Korpela, R. (2002). The effect of a Lactobacillus helveticus LBK-16 H fermented milk on hypertension: A pilot study on humans. Milchwissenschaft 57:124–127.
  • Sharma, S., Singh, R. and Rana, S. (2011). Bioactive peptides: A review. Int. J. Bioautomation 15:223–250.
  • Silva, V. D. M. and Silvestre, M. P. C. (2003). Functional properties of bovine blood plasma intended for use as a functional ingredient in human food. LWT-Food Sci. Technol. 36:709–718.
  • Singh, T. K., Fox, P. F. and Healy, A. (1997). Isolation and identification of further peptides in the diafiltration retentate of water-soluble fraction of Cheddar cheese. J. Dairy Res. 64:433–443.
  • Smacchi, E. and Gobbetti, M. (1998). Peptides from several Italian cheeses inhibitory to proteolytic enzymes of lactic acid bacteria: Pseudomonas fluorescens ATCC 948 and to the angiotensin I-converting enzyme. Enzyme Microbiol. Technol. 22:687–694.
  • Smacchi, E. and Gobbetti, M. (2000). Bioactive peptides in dairy products: Synthesis and interaction with proteolytic enzymes. Food Microbiol. 17:129–141.
  • Stamler, J., Elliott, P., Kesteloot, H., Nichols, R., Claeys, G., Dyer, A. R., et al. (1996). Inverse relation of dietary protein markers with blood pressure. findings of 10,020 men and women in the intersalt study. Intersalt cooperative research group. International Study of Salt and Blood Pressure. Circulation 94:1629–1634.
  • Takano, T. (2002). Anti-hypertensive activity of fermented dairy products containing biogenic peptides. Antonie van Leeuwenhoek. 82:333–340.
  • Tauzin, J., Miclo, L. and Gaillard, J.L. (2002). Angiotensin-I-converting enzyme inhibitory peptides from tryptic hydrolysate of bovine αs2-casein. FEBS Lett. 531:369–374.
  • Thaker, D., Frech, F., Suh, D., et al. (2005). Prevalence of hypertension and ethnic differences in sociodemographic and cardiovascular health characteristics of US hypertensives. Am. J. Hypertens. 18:A117.
  • Theodore, A. E. and Kristinsson, H. G. (2007). Angiotensin converting enzyme inhibition of fish protein hydrolysates prepared from alkaline-aided channel catfish protein isolate. J. Sci. Food Agric. 87:2353–2357.
  • Thomas, G. N., Cheung, B. M., Ho, S. Y., Macfarlane, D. J., Deng, H. B., McGhee, S. M., Woo, J., Lam, T. H., Tomlinson, B. (2007). Overview of dietary influences on atherosclerotic vascular disease: Epidemiology and prevention. Cardiovasc. Hematol. Disord. Drug Targets 7:87–97.
  • Toldra, F., Aristoy, M. C., Mora, L. and Reig, M. (2012). Innovations in value-addition of edible meat by-products. Meat Sci. 92:290–296.
  • Townsend, R. R., McFadden, C. B., Ford, V. and Cadee, J. A. (2004). A randomized, double-blind, placebo-controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension. Am. J. Hypertens. 17:1056–1058.
  • Trziszka, T., Polanowski, A., Saleh, Y. and Kopeć, W. (2006). Egg white isolation and its medical application. Available from http://www.animalscience.com/uploads/additionalfiles/wpsaverona.htm, 2006.
  • Tu, K., Chen, Z. and Lipscombe, L. L. (2008). Prevalence and incidence of hypertension from 1995 to 2005: A population-based study. CMAJ 178:1429–1435.
  • Tuomilehto, J., Lindström, J., Hyyrynen, J., Korpela, R., Karhunen, M. L., Mikkola, L., Jauhiainen, T., Seppo, L., Nissinen, A. (2004). Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension. J. Hum. Hypertens. 18:795–802.
  • Van der Zander, K., Bots, M. L., Bak, A. A., Koning, M. M. and de Leeuw, P. W. (2008a). Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects. Am. J. Clin. Nutr. 88:1697–1702.
  • van der Zander, K., Jäkel, M., Bianco, V., Koning, M. M. (2008b). Fermented lactotripeptides-containing milk lowers daytime blood pressure in high normal-to-mild hypertensive subjects. J. Hum. Hypertens. 22:804–806.
  • van Mierlo, L. A., Arends, L. R., Streppel, M. T., Zeegers, M. P., Kok, F. J., Grobbee, D. E. and Geleijnse, J. M. (2006). Blood pressure response to calcium supplementation: A meta-analysis of randomized controlled trials. J. Hum. Hypertens. 20:571–580.
  • van Mierlo, L. A., Koning, M. M., van der Zander, K. and Draijer, R. (2009). Lactotripeptides do not lower ambulatory blood pressure in untreated whites: Results from 2 controlled multicenter crossover studies. Am. J. Clin. Nutr. 89:617–623.
  • Vercruysse, L., Van Camp, J. and Smagghe, G. (2005). ACE inhibitory peptides derived from enzymatic hydrolysates of animal muscle protein: A review. J. Agric. Food Chem. 53:8106–8115.
  • Wakai, T. and Yamamoto, N. (2012). Antihypertensive peptides specific to lactobacillus helveticus fermented milk, biotechnology—molecular studies and novel applications for improved quality of human life, Prof. Reda Sammour (Ed.), ISBN:978-953-51-0151-2, InTech, Available from: http://www.intechopen.com/books/biotechnology-molecular-studies-and-novel-applications-for-improvedquality-of-human-life/antihypertensive-peptides-specific-to-lactobacillus-helveticus-fermented-milk.
  • Wanasundara, P. K. J. P. D., Ross, A. R. S., Amarowicz, R., Ambrose, S. J., Pegg, R. B. and Shand, P. J. (2002). Peptides with angiotensin I-converting enzyme (ACE) inhibitory activity from defibrinated, hydrolyzed bovine plasma. J. Agric. Food Chem. 50:6981–6988.
  • Wei, J. T. and Chiang, B. H. (2009). Bioactive peptide production by hydrolysis of porcine blood proteins in a continuous enzymatic membrane reactor. J. Sci. Food Agric. 89:372–378.
  • Whelton, P. K., He, J., Appel, L. J., Cutler, J. A., Havas, S., Kotchen, T. A., Roccella, E. J., Stout, R., Vallbona, C., Winston, M. C. and Karimbakas, J. (2002). National high blood pressure education program coordinating committee. Primary prevention of hypertension: Clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 288:1882–1888.
  • Whelton, P. K., He, J., Cutler, J. A., Brancati, F. L., Appel, L. J., Follmann, D. and Klag, M. J. (1997). Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA. 277:1624–1632.
  • Xu, J. Y., Qin, L. Q., Wang, P. Y., Li, W. and Chang, C. (2008). Effect of milk tripeptides on blood pressure: A meta-analysis of randomized controlled trials. Nutrition 24:933–940.
  • Yamada, Y., Matoba, N., Usui, H., Onishi, K. and Yoshikawa, M. (2002). Design of a highly potent anti-hypertensive peptide based on ovokinin (2–7). Biosci. Biotechnol. Biochem. 66:1213–1217.
  • Yamamoto, N., Akino, A. and Takano, T. (1994). Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 77:917–922.
  • Yamamoto, N., Ejiri, M. and Mizuno, S. (2003). Biogenic peptides and their potential use. Curr. Pharm. Des. 9:1345–1355.
  • Yamamoto, N., Maeno, M. and Takano, T. (1999). Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4. J. Dairy Sci. 82:1388–1393.
  • Yoshii, H., Tachi, N., Ohba, R., Sakamura, O., Takeyama, H. and Itani, T. (2001). Antihypertensive effect of ACE inhibitory oligopeptides from chicken egg yolks. Comp. Biochem. Physiol. 128:27–33.
  • Yu, Y., Hu, J., Miyaguchi, Y., Bai, X., Du, Y. and Lin, B. (2006). Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from porcine hemoglobin. Peptides 27:2950–2956.
  • Zhipeng, Y., Wenzhu, Z., Jingbo, L., Jing, L. and Feng, C. (2011). QIGLF, a novel angiotensin I-converting enzyme-inhibitory peptide from egg white protein. J. Sci. Food Agric. 6:921–926.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.